Serum amyloid A

Biomarker1 paper1 finding

Interventions

1

Semaglutide

downin humans1Very low certainty

1 study

Semaglutide decreases serum amyloid A in humans (from 80 to <10 mg/L SAA).
Human trialrenal AA amyloidosis with severe obesitymalesn = 1
Renal AA amyloidosis associated with severe obesity: improvement in kidney function and proteinuria following semaglutide-associated weight loss · Journal of nephrology · 26 Sep 2026

Semaglutide →

Latest

1

Journal of NephrologyResearch26 Sep

Renal AA amyloidosis associated with severe obesity: improvement in kidney function and proteinuria following semaglutide-associated weight loss